Small Molecules

07 Jul 2007 Cobalis Reports Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
06 Jul 2007 SuperGen Reports Dosing of First Patient in Phase I Trial of Novel Tyrosine Kinase Inhibitor
06 Jul 2007 ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
06 Jul 2007 Genaera Discontinues LOMUCIN(TM) in Cystic Fibrosis and Squalamine in Prostate Cancer Studies
06 Jul 2007 Depomed reacquires the rights to ProQuin(R) XR
06 Jul 2007 TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients with NNRTI Resistance in Phase 3 Trials
05 Jul 2007 Cosmo Pharmaceuticals reports positive preliminary Phase II/III data with Rifamycin MMX(TM) in Infectious Diarrhoea
04 Jul 2007 GTx Initiates Phase IIb Ostarine Clinical Trial For Cancer Cachexia
04 Jul 2007 Biomira files investigational new drug application for PX-478, a novel inhibitor of hypoxia-inducible factor-1 alpha
04 Jul 2007 Teva Announces Approval Of Terbinafine Hcl Tablets
03 Jul 2007 Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
03 Jul 2007 VELCADE(R) (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
03 Jul 2007 Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
03 Jul 2007 Biogen Idec and cardiokine partner to develop Lixivaptan, a novel vasopressin antagonist
03 Jul 2007 Ceragenix(TM) Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
03 Jul 2007 Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
03 Jul 2007 Santhera Licenses Omigapil for Treatment of Rare Neuromuscular Diseases
03 Jul 2007 Newron reports positive Phase II results for ralfinamide in neuropathic pain
03 Jul 2007 Spectrum Pharmaceuticals Completes the NDA Filing for ISO-Vorin(TM)
03 Jul 2007 LEO Pharma Submits MAA for Daivobet(R) Scalp gel
03 Jul 2007 Kyoto University and Astellas Co-research at the Innovation Center for Immunoregulation Technologies and Drugs of Next Generation
03 Jul 2007 Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
02 Jul 2007 NicOx SA Initiates Third Pivotal Naproxcinod Phase 3 Study
30 Jun 2007 Rimonabant Regulatory Update in the United States
30 Jun 2007 Cyclacel Pharmaceuticals initiates Phase I study of CYC116 in patients with advanced solid tumors

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top